packageElvitegravir

elvitegravir

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Elvitegravir is an antiviral drug used to treat HIV infections, acting as an integrase inhibitor. It is an approved medicine used in fixed-dose combination antiviral products for HIV treatment, including in the European Union, although one EU product has been withdrawn.

Summary written by glm-5.3-flash from Wikidata Q2740966 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:elvitegravir
ATC codes:J05AJ02, J05AX11
DrugBank:DB09101
PubChem CID:5277135
ChEBI:72289
Wikidata:Q2740966
formula:C23H23ClFNO5
molar mass:447.887 g/mol (PubChem CID 5277135)
logP:5.3 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown